{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T00:45:10Z","timestamp":1794185110427,"version":"4.8.0"},"reference-count":52,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Somatic hypermutation (SHM) targets primarily the immunoglobulin variable region (IgV) genes in germinal center (GC) B cells, thereby allowing antibody affinity maturation. A malfunction of SHM, termed aberrant somatic hypermutation (ASHM), was found in about 50% of diffuse large B-cell lymphomas (DLBCLs), leading to mutations in the 5\u2032 sequences of multiple genes, including oncogenes. Although the SHM mechanism is largely unknown, it was shown to require the activation-induced cytidine deaminase (AID) gene. AID mRNA is expressed in GC B cells and GC-derived lymphomas, but the pattern of expression of the AID protein is not known. Using 2 specific antibodies, here we show that the AID protein can be detected in GC centroblasts and their transformed counterpart (Burkitt lymphoma) but not in pre-GC B cells and post-GC neoplasms, including B-cell chronic lymphocytic leukemia and multiple myeloma. DLBCLs displayed variable levels of AID expression, which did not correlate with IgV ongoing hypermutation, ASHM, or disease subtype. Finally, both in normal and malignant B cells the AID protein appeared predominantly localized in the cytoplasm. These results indicate that the AID protein is specifically expressed in normal and transformed GC B cells; nonetheless, its predominantly cytoplasmic localization suggests that additional mechanisms may regulate its function and may be altered during lymphomagenesis. (Blood. 2004;104:3318-3325)<\/jats:p>","DOI":"10.1182\/blood-2004-04-1558","type":"journal-article","created":{"date-parts":[[2004,8,11]],"date-time":"2004-08-11T01:13:08Z","timestamp":1092186788000},"page":"3318-3325","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":172,"title":["Expression of the AID protein in normal and neoplastic B cells"],"prefix":"10.1182","volume":"104","author":[{"given":"Laura","family":"Pasqualucci","sequence":"first","affiliation":[{"name":"From the Institute for Cancer Genetics and the Departments of Pathology and Genetics & Development, Columbia University, New York, NY; Laboratory of Cancer Genetics and the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; Cell Signaling Technology, Beverly, MA; and INSERM U373 Faculte\u0301 de Me\u0301decine Necker - Enfants Malades, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Guglielmino","sequence":"additional","affiliation":[{"name":"From the Institute for Cancer Genetics and the Departments of Pathology and Genetics & Development, Columbia University, New York, NY; Laboratory of Cancer Genetics and the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; Cell Signaling Technology, Beverly, MA; and INSERM U373 Faculte\u0301 de Me\u0301decine Necker - Enfants Malades, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Houldsworth","sequence":"additional","affiliation":[{"name":"From the Institute for Cancer Genetics and the Departments of Pathology and Genetics & Development, Columbia University, New York, NY; Laboratory of Cancer Genetics and the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; Cell Signaling Technology, Beverly, MA; and INSERM U373 Faculte\u0301 de Me\u0301decine Necker - Enfants Malades, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Mohr","sequence":"additional","affiliation":[{"name":"From the Institute for Cancer Genetics and the Departments of Pathology and Genetics & Development, Columbia University, New York, NY; Laboratory of Cancer Genetics and the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; Cell Signaling Technology, Beverly, MA; and INSERM U373 Faculte\u0301 de Me\u0301decine Necker - Enfants Malades, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said","family":"Aoufouchi","sequence":"additional","affiliation":[{"name":"From the Institute for Cancer Genetics and the Departments of Pathology and Genetics & Development, Columbia University, New York, NY; Laboratory of Cancer Genetics and the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; Cell Signaling Technology, Beverly, MA; and INSERM U373 Faculte\u0301 de Me\u0301decine Necker - Enfants Malades, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Polakiewicz","sequence":"additional","affiliation":[{"name":"From the Institute for Cancer Genetics and the Departments of Pathology and Genetics & Development, Columbia University, New York, NY; Laboratory of Cancer Genetics and the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; Cell Signaling Technology, Beverly, MA; and INSERM U373 Faculte\u0301 de Me\u0301decine Necker - Enfants Malades, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. S. K.","family":"Chaganti","sequence":"additional","affiliation":[{"name":"From the Institute for Cancer Genetics and the Departments of Pathology and Genetics & Development, Columbia University, New York, NY; Laboratory of Cancer Genetics and the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; Cell Signaling Technology, Beverly, MA; and INSERM U373 Faculte\u0301 de Me\u0301decine Necker - Enfants Malades, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Dalla-Favera","sequence":"additional","affiliation":[{"name":"From the Institute for Cancer Genetics and the Departments of Pathology and Genetics & Development, Columbia University, New York, NY; Laboratory of Cancer Genetics and the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; Cell Signaling Technology, Beverly, MA; and INSERM U373 Faculte\u0301 de Me\u0301decine Necker - Enfants Malades, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021300201649800_REF1","doi-asserted-by":"crossref","unstructured":"Jacob J, Kelsoe G, Rajewsky K, Weiss U. Intraclonal generation of antibody mutants in germinal centres. Nature. 1991;354: 389-392.","DOI":"10.1038\/354389a0"},{"key":"2020021300201649800_REF2","doi-asserted-by":"crossref","unstructured":"Liu YJ, de Bouteiller O, Arpin C, et al. Normal human IgD+IgM- germinal center B cells can express up to 80 mutations in the variable region of their IgD transcripts. Immunity. 1996;4: 603-613.","DOI":"10.1016\/S1074-7613(00)80486-0"},{"key":"2020021300201649800_REF3","doi-asserted-by":"crossref","unstructured":"Rajewsky K. Clonal selection and learning in the antibody system. Nature. 1996;381: 751-758.","DOI":"10.1038\/381751a0"},{"key":"2020021300201649800_REF4","doi-asserted-by":"crossref","unstructured":"Peters A, Storb U. Somatic hypermutation of immunoglobulin genes is linked to transcription initiation. Immunity. 1996;4: 57-65.","DOI":"10.1016\/S1074-7613(00)80298-8"},{"key":"2020021300201649800_REF5","doi-asserted-by":"crossref","unstructured":"Tumas-Brundage K, Manser T. The transcriptional promoter regulates hypermutation of the antibody heavy chain locus. J Exp Med. 1997;185: 239-250.","DOI":"10.1084\/jem.185.2.239"},{"key":"2020021300201649800_REF6","doi-asserted-by":"crossref","unstructured":"Fukita Y, Jacobs H, Rajewsky K. Somatic hypermutation in the heavy chain locus correlates with transcription. Immunity. 1998;9: 105-114.","DOI":"10.1016\/S1074-7613(00)80592-0"},{"key":"2020021300201649800_REF7","doi-asserted-by":"crossref","unstructured":"Yelamos J, Klix N, Goyenechea B, et al. Targeting of non-Ig sequences in place of the V segment by somatic hypermutation. Nature. 1995;376: 225-229.","DOI":"10.1038\/376225a0"},{"key":"2020021300201649800_REF8","doi-asserted-by":"crossref","unstructured":"Pasqualucci L, Migliazza A, Fracchiolla N, et al. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci U S A. 1998;95: 11816-11821.","DOI":"10.1073\/pnas.95.20.11816"},{"key":"2020021300201649800_REF9","doi-asserted-by":"crossref","unstructured":"Shen HM, Peters A, Baron B, Zhu X, Storb U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science. 1998;280: 1750-1752.","DOI":"10.1126\/science.280.5370.1750"},{"key":"2020021300201649800_REF10","doi-asserted-by":"crossref","unstructured":"Peng HZ, Du MQ, Koulis A, et al. Nonimmunoglobulin gene hypermutation in germinal center B cells. Blood. 1999;93: 2167-2172.","DOI":"10.1182\/blood.V93.7.2167"},{"key":"2020021300201649800_REF11","doi-asserted-by":"crossref","unstructured":"Mu\u0308schen M, Re D, Jungnickel B, Diehl V, Rajewsky K, Ku\u0308ppers R. Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction. J Exp Med. 2000;192: 1833-1840.","DOI":"10.1084\/jem.192.12.1833"},{"key":"2020021300201649800_REF12","doi-asserted-by":"crossref","unstructured":"Gordon MS, Kanegai CM, Doerr JR, Wall R. Somatic hypermutation of the B cell receptor genes B29 (Igbeta, CD79b) and mb1 (Igalpha, CD79a). Proc Natl Acad Sci U S A. 2003;100: 4126-4131.","DOI":"10.1073\/pnas.0735266100"},{"key":"2020021300201649800_REF13","doi-asserted-by":"crossref","unstructured":"Revy P, Muto T, Levy Y, et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell. 2000;102: 565-575.","DOI":"10.1016\/S0092-8674(00)00079-9"},{"key":"2020021300201649800_REF14","doi-asserted-by":"crossref","unstructured":"Muramatsu M, Kinoshita K, Fagarasan S, et al. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA-editing enzyme. Cell. 2000;102: 553-563.","DOI":"10.1016\/S0092-8674(00)00078-7"},{"key":"2020021300201649800_REF15","doi-asserted-by":"crossref","unstructured":"Yoshikawa K, Okazaki IM, Eto T, et al. AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts. Science. 2002;296: 2033-2036.","DOI":"10.1126\/science.1071556"},{"key":"2020021300201649800_REF16","doi-asserted-by":"crossref","unstructured":"Okazaki IM, Kinoshita K, Muramatsu M, Yoshikawa K, Honjo T. The AID enzyme induces class switch recombination in fibroblasts. Nature. 2002;416: 340-345.","DOI":"10.1038\/nature727"},{"key":"2020021300201649800_REF17","doi-asserted-by":"crossref","unstructured":"Doi T, Kinoshita K, Ikegawa M, Muramatsu M, Honjo T. De novo protein synthesis is required for the activation-induced cytidine deaminase function in class-switch recombination. Proc Natl Acad Sci U S A. 2003;100: 2634-2638.","DOI":"10.1073\/pnas.0437710100"},{"key":"2020021300201649800_REF18","doi-asserted-by":"crossref","unstructured":"Petersen-Mahrt SK, Harris RS, Neuberger MS. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature. 2002;418: 99-103.","DOI":"10.1038\/nature00862"},{"key":"2020021300201649800_REF19","doi-asserted-by":"crossref","unstructured":"Chaudhuri J, Tian M, Khuong C, Chua K, Pinaud E, Alt FW. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature. 2003;422: 726-730.","DOI":"10.1038\/nature01574"},{"key":"2020021300201649800_REF20","doi-asserted-by":"crossref","unstructured":"Pham P, Bransteitter R, Petruska J, Goodman MF. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature. 2003;424: 103-107.","DOI":"10.1038\/nature01760"},{"key":"2020021300201649800_REF21","doi-asserted-by":"crossref","unstructured":"Ramiro AR, Stavropoulos P, Jankovic M, Nussenzweig MC. Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand. Nat Immunol. 2003;4: 452-456.","DOI":"10.1038\/ni920"},{"key":"2020021300201649800_REF22","doi-asserted-by":"crossref","unstructured":"Dickerson SK, Market E, Besmer E, Papavasiliou FN. AID mediates hypermutation by deaminating single stranded DNA. J Exp Med. 2003;197: 1291-1296.","DOI":"10.1084\/jem.20030481"},{"key":"2020021300201649800_REF23","doi-asserted-by":"crossref","unstructured":"Pasqualucci L, Neumeister P, Goossens T, et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature. 2001;412: 341-346.","DOI":"10.1038\/35085588"},{"key":"2020021300201649800_REF24","doi-asserted-by":"crossref","unstructured":"Gaidano G, Pasqualucci L, Capello D, et al. Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma. Blood. 2003;102: 1833-1841.","DOI":"10.1182\/blood-2002-11-3606"},{"key":"2020021300201649800_REF25","doi-asserted-by":"crossref","unstructured":"Montesinos-Rongen M, Van Roost D, Schaller C, Wiestler OD, Deckert M. Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation. Blood. 2004;103: 1869-1875.","DOI":"10.1182\/blood-2003-05-1465"},{"key":"2020021300201649800_REF26","doi-asserted-by":"crossref","unstructured":"Gregory MA, Hann SR. c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Mol Cell Biol. 2000;20: 2423-2435.","DOI":"10.1128\/MCB.20.7.2423-2435.2000"},{"key":"2020021300201649800_REF27","doi-asserted-by":"crossref","unstructured":"Bahram F, von der Lehr N, Cetinkaya C, Larsson LG. c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover. Blood. 2000;95: 2104-2110.","DOI":"10.1182\/blood.V95.6.2104"},{"key":"2020021300201649800_REF28","doi-asserted-by":"crossref","unstructured":"Yeh E, Cunningham M, Arnold H, et al. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol. 2004;6: 308-318.","DOI":"10.1038\/ncb1110"},{"key":"2020021300201649800_REF29","doi-asserted-by":"crossref","unstructured":"Greeve J, Philipsen A, Krause K, et al. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. Blood. 2003;101: 3574-3580.","DOI":"10.1182\/blood-2002-08-2424"},{"key":"2020021300201649800_REF30","unstructured":"Smit LA, Bende RJ, Aten J, Guikema JE, Aarts WM, van Noesel CJ. Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype. Cancer Res. 2003;63: 3894-3898."},{"key":"2020021300201649800_REF31","doi-asserted-by":"crossref","unstructured":"Hardianti MS, Tatsumi E, Syampurnawati M, et al. Activation-induced cytidine deaminase expression in follicular lymphoma: association between AID expression and ongoing mutation in FL. Leukemia. 2004;18: 826-831.","DOI":"10.1038\/sj.leu.2403323"},{"key":"2020021300201649800_REF32","doi-asserted-by":"crossref","unstructured":"Houldsworth J, Olshen AB, Cattoretti G, et al. Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas. Blood. 2004;103: 1862-1868.","DOI":"10.1182\/blood-2003-04-1359"},{"key":"2020021300201649800_REF33","unstructured":"Pasqualucci L, Neri A, Baldini L, Dalla-Favera R, Migliazza A. BCL-6 mutations are associated with immunoglobulin variable heavy chain mutations in B-cell chronic lymphocytic leukemia. Cancer Res. 2000;60: 5644-5648."},{"key":"2020021300201649800_REF34","doi-asserted-by":"crossref","unstructured":"Klein U, Tu Y, Stolovitzky GA, et al. Transcriptional analysis of the B cell germinal center reaction. Proc Natl Acad Sci U S A. 2003;100: 2639-2644.","DOI":"10.1073\/pnas.0437996100"},{"key":"2020021300201649800_REF35","doi-asserted-by":"crossref","unstructured":"Faili A, Aoufouchi S, Gueranger Q, et al. AID-dependent somatic hypermutation occurs as a DNA single-strand event in the BL2 cell line. Nat Immunol. 2002;3: 815-821.","DOI":"10.1038\/ni826"},{"key":"2020021300201649800_REF36","doi-asserted-by":"crossref","unstructured":"Niu H, Ye BH, Dalla-Favera R. Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor. Genes Dev. 1998;12: 1953-1961.","DOI":"10.1101\/gad.12.13.1953"},{"key":"2020021300201649800_REF37","doi-asserted-by":"crossref","unstructured":"Rowe M, Khanna R, Jacob CA, et al. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Eur J Immunol. 1995;25: 1374-1384.","DOI":"10.1002\/eji.1830250536"},{"key":"2020021300201649800_REF38","doi-asserted-by":"crossref","unstructured":"Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403: 503-511.","DOI":"10.1038\/35000501"},{"key":"2020021300201649800_REF39","doi-asserted-by":"crossref","unstructured":"Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346: 1937-1947.","DOI":"10.1056\/NEJMoa012914"},{"key":"2020021300201649800_REF40","doi-asserted-by":"crossref","unstructured":"Zhang W, Bardwell PD, Woo CJ, Poltoratsky V, Scharff MD, Martin A. Clonal instability of V region hypermutation in the Ramos Burkitt's lymphoma cell line. Int Immunol. 2001;13: 1175-1184.","DOI":"10.1093\/intimm\/13.9.1175"},{"key":"2020021300201649800_REF41","doi-asserted-by":"crossref","unstructured":"Klein U, Tu Y, Stolovitzky GA, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med. 2001;194: 1625-1638.","DOI":"10.1084\/jem.194.11.1625"},{"key":"2020021300201649800_REF42","doi-asserted-by":"crossref","unstructured":"Oppezzo P, Vuillier F, Vasconcelos Y, et al. Chronic lymphocytic leukemia B cells expressing AID display dissociation between class switch recombination and somatic hypermutation. Blood. 2003;101: 4029-4032.","DOI":"10.1182\/blood-2002-10-3175"},{"key":"2020021300201649800_REF43","doi-asserted-by":"crossref","unstructured":"Heintel D, Kroemer E, Kienle D, et al. High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia. Leukemia. 2004;18: 756-762.","DOI":"10.1038\/sj.leu.2403294"},{"key":"2020021300201649800_REF44","doi-asserted-by":"crossref","unstructured":"Albesiano E, Messmer BT, Damle RN, Allen SL, Rai KR, Chiorazzi N. Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone. Blood. 2003;102: 3333-3339.","DOI":"10.1182\/blood-2003-05-1585"},{"key":"2020021300201649800_REF45","doi-asserted-by":"crossref","unstructured":"McCarthy H, Wierda WG, Barron LL, et al. High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia. Blood. 2003;101: 4903-4908.","DOI":"10.1182\/blood-2002-09-2906"},{"key":"2020021300201649800_REF46","doi-asserted-by":"crossref","unstructured":"Wright G, Tan B, Rosenwald A, Hurt EH, Wiestner A, Staudt LM. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci U S A. 2003;100: 9991-9996.","DOI":"10.1073\/pnas.1732008100"},{"key":"2020021300201649800_REF47","doi-asserted-by":"crossref","unstructured":"Lossos IS, Alizadeh AA, Eisen MB, et al. Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proc Natl Acad Sci U S A. 2000;97: 10209-10213.","DOI":"10.1073\/pnas.180316097"},{"key":"2020021300201649800_REF48","doi-asserted-by":"crossref","unstructured":"Shaffer AL, Rosenwald A, Staudt LM. Lymphoid malignancies: the dark side of B-cell differentiation. Nat Rev Immunol. 2002;2: 920-932.","DOI":"10.1038\/nri953"},{"key":"2020021300201649800_REF49","doi-asserted-by":"crossref","unstructured":"Rada C, Jarvis JM, Milstein C. AID-GFP chimeric protein increases hypermutation of Ig genes with no evidence of nuclear localization. Proc Natl Acad Sci U S A. 2002;99: 7003-7008.","DOI":"10.1073\/pnas.092160999"},{"key":"2020021300201649800_REF50","doi-asserted-by":"crossref","unstructured":"Ito S, Nagaoka H, Shinkura R, et al. Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1. Proc Natl Acad Sci U S A. 2004;101: 1975-1980.","DOI":"10.1073\/pnas.0307335101"},{"key":"2020021300201649800_REF51","doi-asserted-by":"crossref","unstructured":"McBride KM, Barreto V, Ramiro AR, Stavropoulos P, Nussenzweig MC. Somatic hypermutation is limited by CRM1-dependent nuclear export of activation-induced deaminase. J Exp Med. 2004;199: 1235-1244.","DOI":"10.1084\/jem.20040373"},{"key":"2020021300201649800_REF52","doi-asserted-by":"crossref","unstructured":"Wedekind JE, Dance GS, Sowden MP, Smith HC. Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business. Trends Genet. 2003;19: 207-216.","DOI":"10.1016\/S0168-9525(03)00054-4"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/10\/3318\/1703591\/zh802204003318.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/10\/3318\/1703591\/zh802204003318.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T05:20:32Z","timestamp":1581571232000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/104\/10\/3318\/18758\/Expression-of-the-AID-protein-in-normal-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,15]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,11,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-04-1558","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,15]]}}}